Sector: Health Care
Director information for CAREDX INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Abhishek Jain | Chief Financial Officer | [] | [] | 2026 | |
| Arthur A. Torres | Independent Director | 79 | ["Regulatory and Legal Experience","Relevant Industry Knowledge","ESG"] | ["Governance & Nominating Committee"] | 2026 |
| Christine M. Cournoyer | Independent Director | 74 | ["Chairman & CEO, N-of-One (2012 - 2019)","Vice President (Clinical Analytics), Optum (2010 - 2011)","President & COO, Picis (2006 - 2010)","Managing Director (Solutions), Harte-Hanks (2005 - 2006)","CIO & Division Vice President, IBM (1995 - 2002)","SVP, CIO, Lotus Development (1994 - 1995)","Extensive experience as an executive in the life sciences industry and healthcare technology","M&A or Corporate Development Experience","Investment, Finance or Accounting Experience","Risk Management expertise"] | ["Audit & Finance","Compensation & Human Capital","Compensation and Human Capital Committee"] | 2026 |
| Fred E. Cohen, M.D., D. Phil | Independent Director | 69 | ["Founder & Chairman, Monograph Capital Partners (2021 - Present)","Founder & Senior Managing Director, Vida Ventures (2017 - Present)","Senior Advisor & Retired Partner, TPG (2001 - Present)","Professor (Cellular and Molecular Pharmacology), University of California, San Francisco (UCSF) (1988 - 2016)","Dr. Cohen’s thought leadership in biotechnology","Investment and financial matters specific to biotechnology companies","Public company board experience including Progyny, Intellia Therapeutics and Urogen Pharma"] | ["Technology and Innovation Committee","Governance and Nominating Committee","Compensation and Human Capital Committee"] | 2026 |
| George W. Bickerstaff | Independent Director | 70 | ["Partner & MD, M.M. Dillon & Co. (2005 - Present)","CFO, Novartis Pharma AG (2000 - 2005)","EVP & CFO, Workspace (1999 - 2000)","EVP & CFO, Uniscribe Professional Services (1998 - 1999)","EVP & CFO, Intellisource Group (1998)","Vice President (Finance), Cognizant (1997)","CFO, IMS Health (1990 - 1997)","Senior Vice President (Finance), Dun & Bradstreet (1985 – 1989)","Auditor & Engineer, General Electric (1978 - 1984)","Extensive experience in financial leadership, healthcare operations, and public company governance","Expertise in financial reporting, capital markets, mergers and acquisitions, and risk management","Substantial experience in public company board service, including audit, finance, and governance oversight"] | ["Audit & Finance Committee","Governance & Nominating Committee","Compensation & Human Capital Committee"] | 2026 |
| George W. Bickerstaff, III | Director | 70 | [] | ["Audit and Finance Committee","Governance and Nominating Committee","Compensation and Human Capital Committee","Technology and Innovation Committee"] | 2026 |
| Hannah A. Valantine, M.D. | Independent Director | 74 | ["Professor of Medicine, Stanford School of Medicine (2000 - Present)","Chief Officer (Scientific Workforce Diversity), National Institutes of Health (2014 - 2020)","Senior Associate Dean for Diversity and Leadership, Stanford School of Medicine (2005 - 2014)","Assistant Professor of Medicine, Stanford School of Medicine (1987 - 2000)","Registrar, Hammersmith Hospitals NHS Trust","Relevant Industry Knowledge in transplant medicine","Expertise in genomic-based diagnostics for acute rejection","Experience in ESG matters","Recognized for enhancing gender and racial diversity"] | ["Governance & Nominating Committee","Technology and Innovation Committee (Chairwoman)","Compensation and Human Capital Committee"] | 2026 |
| John W. Hanna | Director, President and Chief Executive Officer | 46 | ["Over two decades of experience in the molecular diagnostics and life sciences tools industries.","Business and Operations Leadership Experience","CEO of Apton Biosystems, Inc.","Vice President of Corporate Development at Pacific Biosciences of California, Inc.","Chief Commercial Officer at Veracyte, Inc.","Held leadership roles at Humana and IBM."] | [] | 2026 |
| Keith Kennedy | Chief Operating Officer and Chief Financial Officer | [] | [] | 2026 | |
| Michael D. Goldberg | Chairman of the Board of Directors | 68 | ["Partner, Mohr Davidow Ventures (2005 - 2011)","Founder & CEO, Axion (1987 - 1995) (acquired by Bristol-Myers Squibb, NYSE: BMS)","Partner, Sevin Rosen Management Company (1985 - 1987)","Director (Corporate Development), Cetus Corporation (1981 - 1985)","Relevant Industry Knowledge in healthcare and precision medicine","Public Company Board or Governance Experience","Business and Operations Leadership Experience in the Life Sciences industry"] | ["Compensation and Human Capital Committee"] | 2026 |
| Nathan Smith | Chief Financial Officer | [] | [] | 2026 | |
| Peter K. Maag, Ph.D. | Independent Director | 59 | ["20+ years of executive management experience in the pharmaceutical and diagnostic industry","Risk management expertise","M&A or corporate development experience"] | ["Technology and Innovation Committee"] | 2026 |
| Peter Maag, Ph.D. | Director | 59 | [] | [] | 2026 |
| R. Bryan Riggsbee | Independent Director | 55 | ["Senior Vice President, CFO - Neogen Corporation (Nasdaq: NEOG) (2025-present)","Independent Director, Member of the Audit Committee, Member of the Remuneration Committee - Immunovia AB (2025 - present)","Senior Vice President, CFO - North America, BioMerieux (2025)","CFO, Myriad Genetics (Nasdaq: MYGN) (2014 – 2024)","Interim President and CEO, Myriad Genetics (Nasdaq: MYGN) (2020)","Senior Vice President, Corporate Finance, Laboratory Corporation of America (LabCorp) (NYSE: LH) (2004-2014)","Financial Planning and Analysis","Strategic Planning","Risk Management","Compliance and Regulatory Standards","Treasury","Certified Public Accountant licensed in the state of North Carolina"] | ["Audit & Finance Committee (Chairman)","Compensation and Human Capital Committee"] | 2026 |
| Suresh Gunasekaran | Director; CEO, UCSF Health | 50 | ["President and CEO, UCSF Health (2022 - Present)","CEO and the Associate Vice President, University of Iowa Hospitals & Clinics (2018 - 2022)","Senior Executive Officer, Southwestern Health Resources Population Health Services Company (2017 - 2018)","Associate Vice President, Health System Affairs & CIO, Southwestern Medical Center (2004 - 2014)","Chief Operations Officer, UT Southwestern Medical Center (2015 - 2018)","More than 20 years of executive leadership experience in healthcare administration and information technology","Track record leading large, complex academic medical centers","Leadership experience at Vanderbilt Children’s Hospital"] | [] | 2026 |
